← Company intelligence

Robot maker · registered

Noah Medical

Corporate marketmedicalCurated record

Galaxy System uses Embedded Imaging Technology (EIT) for real-time tool-in-lesion visualization and adaptive AI-guided scope navigation; co-registers pre-operative CT with live bronchoscopic view; autonomous nodule targeting for pulmonary biopsy; 96.7% diagnostic yield reported in MATCH II Study; NVIDIA Isaac for Healthcare integration in development.

HeadquartersSan Carlos, US
Founded2018
Corporate funding$150M
Team201-500
Deployments8
Open roles18
01

Company overview

Identity and operating footprint

Company typeRobot maker
Market segmentCorporate
StageSeries B
FoundersJian Zhang (Founder & CEO)
Regions servedNorth America, Oceania
Countries deployedUS, AU
Service footprintGalaxy System robotic bronchoscopy platform deployed at academic and community hospitals across the United States; first-in-human trial at Macquarie University Hospital, Sydney, Australia; 5,000+ US procedures as of March 2025.
Last reviewed2026-07-05
MX

Robot models

Specifications remain vendor-claimed

Machinemedical

Galaxy System

  • FDA cleared for robotic navigated bronchoscopy

    vendor-stated US regulatory clearance for bronchoscopic visualization and access to patient airways

    Claim source
  • 96.7% diagnostic yield (MATCH II Study, 31 patients)

    vendor-cited clinical study result for pulmonary nodule biopsy

    Claim source
  • 5,000+ procedures completed in the United States

    vendor-stated cumulative US procedure count milestone as of March 2025

    Claim source
DP

Deployment log

Announced and cited only

AnnouncedCustomerSiteCountryCountEvidence
2026-03-11Inova Health Systemacademic medical center, interventional pulmonologyUSNot disclosedAnnouncement
2025-03-24Long Island Jewish Medical Centeracademic medical center, interventional pulmonologyUSNot disclosedAnnouncement
2025-02-05Meadville Medical Centerhospital bronchoscopyUSNot disclosedAnnouncement
2024-11-08Inova Fairfax Medical Campusclinical use — NCT06685133UnNot disclosedAnnouncement
2024-01-24CHI Memorial (Chattanooga, TN)hospital bronchoscopyUSNot disclosedAnnouncement
2023-12-05Prince of Wales HospitalhospitalHKNot disclosedAnnouncement
2023-03-13Macquarie University HospitalhospitalAUNot disclosedAnnouncement
2023-03-02University of Chicago Medicineacademic medical center, interventional pulmonologyUSNot disclosedAnnouncement
CA

Funding history

Publicly announced rounds

Investors on recordSoftBank Vision FundProsperity7 VenturesTiger GlobalHillhouseLyfe Capital1955 CapitalAME Cloud VenturesAramco Ventures
HR

Hiring signal

Public job board · 2026-08-10

Open roles18

Hiring is an operating signal, not deployment evidence. Roles are refreshed from the company’s public careers system.

TL

Company timeline

Milestones and announcements

2026-03-11MATCH 2 study published in Respiratory Medicine: 96.7% diagnostic yield in 31-patient robotic bronchoscopy trial at Inova Health System: validates real-time embedded imaging guidanceGlobeNewswire
2025-10-01Two new clinical studies presented at CHEST 2025 demonstrating Galaxy System diagnostic performance and economic efficiency in academic and community hospital settingsNoah Medical
2025-03-24Galaxy System surpassed 5,000 procedures in the United States; milestone procedure performed at Long Island Jewish Medical CenterNoah Medical
2023-04-19Raised $150M Series B led by SoftBank Vision Fund and Prosperity7 Ventures to scale Galaxy System commercial rolloutGlobeNewswire
2023-03-02Galaxy System received FDA 510(k) clearance for robotic navigated bronchoscopy; first US clinical use at University of Chicago MedicineNoah Medical
SC

Source ledger

11 unique public sources